Last reviewed · How we verify

NCT05906940

Vagus Nerve Stimulation for Autonomic Nervous System Activity

Completed NA Last updated 5 January 2024
What this trial tests

NA trial testing Transcutaneous Vagus Nerve Stimulation in Autonomic Nervous System Imbalance in 72 participants. Completed in 30 December 2023.

Timeline
1 July 2023
Primary endpoint
1 December 2023
30 December 2023

Quick facts

Lead sponsorBahçeşehir University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment72
Start date1 July 2023
Primary completion1 December 2023
Estimated completion30 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bahçeşehir University

Who can join

Adults 18 to 45, any sex, with Autonomic Nervous System Imbalance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are no generally accepted values for transcutaneous vagus nerve stimulation (taVSS application parameters (amplitude, frequency, intensity, duration, side) yet, therefore there are heterogeneous applications in studies. Although positive effects have been shown in different neurological, psychiatric and musculoskeletal diseases, taVSS treatment is not available yet. It is not clear which parameters are important in patient selection.In this study, it was aimed to investigate the change of taVSS effect in healthy individuals according to the level of autonomic nervous system activity before stimulation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcutaneous Vagus Nerve Stimulation

Trials testing the same drug.

Other recruiting trials for Autonomic Nervous System Imbalance

Currently open trials in the same condition.

Other Bahçeşehir University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05906940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing